| Cytokine-cytokine receptor interaction |
21 |
8.40E-15 |
| TGF-beta signaling pathway |
11 |
2.85E-10 |
| Cell adhesion molecules (CAMs) |
12 |
1.88E-09 |
| MAPK signaling pathway |
15 |
8.17E-09 |
| Graft-versus-host disease |
5 |
4.30E-05 |
| Jak-STAT signaling pathway |
8 |
4.62E-05 |
| Chondroitin sulfate biosynthesis |
4 |
5.91E-05 |
| O-Glycan biosynthesis |
4 |
2.11E-04 |
| Focal adhesion |
8 |
2.67E-04 |
| Type I diabetes mellitus |
4 |
6.58E-04 |
| Axon guidance |
6 |
7.15E-04 |
| ECM-receptor interaction |
5 |
7.41E-04 |
| Hematopoietic cell lineage |
5 |
8.33E-04 |
| Wnt signaling pathway |
6 |
0.001391 |
| Glycosphingolipid biosynthesis – lactoseries |
3 |
0.001572 |
| Complement and coagulation cascades |
4 |
0.002474 |
| Melanoma |
4 |
0.002728 |
| Calcium signaling pathway |
6 |
0.002957 |
| Bladder cancer |
3 |
0.00505 |
| Prostate cancer |
4 |
0.005125 |
| ABC transporters – General |
3 |
0.005554 |
| Regulation of actin cytoskeleton |
6 |
0.00583 |
| Gap junction |
4 |
0.00598 |
| Glycerolipid metabolism |
3 |
0.006415 |
| Toll-like receptor signaling pathway |
4 |
0.007696 |
